華文網

天津首次在頂級期刊JAMA發文:老年人補鈣和維生素D不能預防骨折

趙嘉國,男,1982年出生,博士,2015年破格晉升副主任醫師。從事足踝外科、創傷骨科和Cochrane循證醫學的工作。

主要研究方向是足踝運動損傷的診治、骨質疏鬆骨折的預防、臨床流行病學和循證決策、循證方法學。是國際權威的循證醫學組織Cochrane協作網骨關節肌肉創傷協作組負責專案最多的中國學者,創新性地對Cochanre品質評價方法進行改良,是國內最早將Jadad原則應用於評價重複發表的系統評價的學者。目前擔任中華醫學會骨科分會足踝外科學組青年委員,
中國醫促會足踝外科學組天津分會秘書、中國循證醫學雜誌青年編委。第一作者或通訊作者在國際一流綜合及骨科期刊如JAMA、Cochrane、Arthroscopy、CORR等雜誌發表SCI收錄論文20餘篇,發表了天津市第一篇Cochrane系統評價,累計影響因數110餘分。碩士學位論文獲得2009年遼寧省和中國醫科大學優秀碩士學位論文。目前擔任10餘本SCI期刊審稿專家。

JAMA,2017年12月26日318(24):2466-2482

補鈣或補充維生素D與社區居住的老年人骨折發生率的相關性——一項系統性評價和薈萃分析

Jia-Guo Zhao, MD1; Xian-Tie Zeng, MD1; Jia Wang, MD1; et al Lin Liu, MD2

·1Department of Orthopaedic Surgery, Tianjin Hospital, Tianjin, China

·2Department of Orthopaedic Surgery, Hebei Province Cangzhou Hospital of Integrated Traditional and Western Medicine, Cangzhou, China

JAMA. 2017;318(24):2466-2482. doi:10.1001/jama.2017.19344

要點

問題:在社區居住的老年人中補鈣、補充維生素或者兩者聯合補充是否與較低的骨折發生率相關?

結果發現:在對共計納入了51145名參試者的33項隨機化臨床試驗的薈萃分析中發現,使用含鈣、維生素D或兩者都有的補充劑,與安慰劑或不治療相比,髖部骨折的風險並沒有顯著差異(風險比分別為1.53、1.21、1.09)。

意義:所發現的這些結果並不支持在社區居住的老年人中常規使用這類補充劑。

《壹篇》南南和北北

December 26, 2017

Association Between Calcium or Vitamin D Supplementation and Fracture Incidence in Community-Dwelling Older AdultsA Systematic Review and Meta-analysis

Jia-Guo Zhao, MD1; Xian-Tie Zeng, MD1; Jia Wang, MD1; et al Lin Liu, MD2

·1Department of Orthopaedic Surgery, Tianjin Hospital, Tianjin, China

·2Department of Orthopaedic Surgery, Hebei Province Cangzhou Hospital of Integrated Traditional and Western Medicine, Cangzhou, China

JAMA. 2017;318(24):2466-2482. doi:10.1001/jama.2017.19344

Key Points

Question Is supplementation with calcium, vitamin D, or combined calcium and vitamin D associated with a lower fracture incidence in community-dwelling older adults?

Findings In this meta-analysis of 33 randomized clinical trials that included 51 145 participants, the use of supplements that included calcium, vitamin D, or both was not associated with a significant difference in the risk of hip fractures compared with placebo or no treatment (risk ratio, 1.53, 1.21, and 1.09, respectively).

Meaning These findings do not support the routine use of these supplements in community-dwelling older adults.

Abstract

Importance The increased social and economic burdens for osteoporosis-related fractures worldwide make the prevention of such injuries a major public health goal. Previous studies have reached mixed conclusions regarding the association between calcium, vitamin D, or combined calcium and vitamin D supplements and fracture incidence in older adults.

Objective To investigate whether calcium, vitamin D, or combined calcium and vitamin D supplements are associated with a lower fracture incidence in community-dwelling older adults.

Data Sources The PubMed, Cochrane library, and EMBASE databases were systematically searched from the inception dates to December 24, 2016, using the keywords calcium, vitamin D, and fracture to identify systematic reviews or meta-analyses. The primary randomized clinical trials included in systematic reviews or meta-analyses were identified, and an additional search for recently published randomized trials was performed from July 16, 2012, to July 16, 2017.

Study Selection Randomized clinical trials comparing calcium, vitamin D, or combined calcium and vitamin D supplements with a placebo or no treatment for fracture incidence in community-dwelling adults older than 50 years.

Data Extraction and Synthesis Two independent reviewers performed the data extraction and assessed study quality. A meta-analysis was performed to calculate risk ratios (RRs), absolute risk differences (ARDs), and 95% CIs using random-effects models.

Main Outcomes and Measures Hip fracture was defined as the primary outcome. Secondary outcomes were nonvertebral fracture, vertebral fracture, and total fracture.

Results A total of 33 randomized trials involving 51 145 participants fulfilled the inclusion criteria. There was no significant association of calcium or vitamin D with risk of hip fracture compared with placebo or no treatment (calcium: RR, 1.53 [95% CI, 0.97 to 2.42]; ARD, 0.01 [95% CI, 0.00 to 0.01]; vitamin D: RR, 1.21 [95% CI, 0.99 to 1.47]; ARD, 0.00 [95% CI, −0.00 to 0.01]. There was no significant association of combined calcium and vitamin D with hip fracture compared with placebo or no treatment (RR, 1.09 [95% CI, 0.85 to 1.39]; ARD, 0.00 [95% CI, −0.00 to 0.00]). No significant associations were found between calcium, vitamin D, or combined calcium and vitamin D supplements and the incidence of nonvertebral, vertebral, or total fractures. Subgroup analyses showed that these results were generally consistent regardless of the calcium or vitamin D dose, sex, fracture history, dietary calcium intake, and baseline serum 25-hydroxyvitamin D concentration.

Conclusions and Relevance In this meta-analysis of randomized clinical trials, the use of supplements that included calcium, vitamin D, or both compared with placebo or no treatment was not associated with a lower risk of fractures among community-dwelling older adults. These findings do not support the routine use of these supplements in community-dwelling older people.

《壹篇》(與桓興醫訊同步)系主要面向醫務人員的公益性頭條號,不以營利為目的,不進行任何有償諮詢和服務,不出售任何產品,與ASCO、CSCO等所有專業學會和機構沒有任何關係和聯繫,

也不代表任何官方學會發聲。

文章圖片均來自網路,不做商業用途,若有版權爭議請與《壹篇》聯繫。

堅持點贊、讚賞和轉發是一種態度和支持。